
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties no_embargo?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Crystallogr Sect F Struct Biol Cryst Commun</journal-id><journal-id journal-id-type="publisher-id">Acta Cryst. F</journal-id><journal-title>Acta Crystallographica Section F: Structural Biology and Crystallization Communications</journal-title><issn pub-type="epub">1744-3091</issn><publisher><publisher-name>International Union of Crystallography</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">2225206</article-id><article-id pub-id-type="publisher-id">bw5180</article-id><article-id pub-id-type="doi">10.1107/S1744309106044150</article-id><article-id pub-id-type="coden">ACSFCL</article-id><article-id pub-id-type="pii">S1744309106044150</article-id><article-categories><subj-group subj-group-type="heading"><subject>Crystallization Communications</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Crystallization and preliminary X-ray diffraction analysis of two N-terminal fragments of the DNA-cleavage domain of topoisomerase IV from Staphylococcus aureus </plain></SENT>
</text></SecTag></article-title><alt-title>Topoisomerase IV</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Carr</surname><given-names>Stephen B.</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="corresp" rid="cor">*</xref></contrib><contrib contrib-type="author"><name><surname>Makris</surname><given-names>George</given-names></name><xref ref-type="aff" rid="b">b</xref></contrib><contrib contrib-type="author"><name><surname>Phillips</surname><given-names>Simon E. V.</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Thomas</surname><given-names>Christopher D.</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><aff id="a"><label>a</label>Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, <country>England</country></aff><aff id="b"><label>b</label>Omega Mediation Hellas Ltd, Clinical and Pharma Consulting, 11525 N. Psychiko, Athens, <country>Greece</country></aff></contrib-group><author-notes><corresp id="cor">Correspondence e-mail: <email>bmbsbc@bmb.leeds.ac.uk</email></corresp></author-notes><pub-date pub-type="collection"><day>01</day><month>11</month><year>2006</year></pub-date><pub-date pub-type="epub"><day>28</day><month>10</month><year>2006</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>11</month><year>2006</year></pub-date><volume>62</volume><issue>Pt 11</issue><issue-id pub-id-type="publisher-id">f061100</issue-id><fpage>1164</fpage><lpage>1167</lpage><history><date date-type="received"><day>11</day><month>10</month><year>2006</year></date><date date-type="accepted"><day>23</day><month>10</month><year>2006</year></date></history><permissions><copyright-statement>© International Union of Crystallography 2006</copyright-statement><copyright-year>2006</copyright-year><license license-type="open-access" xlink:href="http://journals.iucr.org/services/termsofuse.html"><p>This is an open-access article distributed under the terms described at http://journals.iucr.org/services/termsofuse.html.</p></license></permissions><self-uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1107/S1744309106044150">A full version of this article is available from Crystallography Journals Online.</self-uri><abstract abstract-type="toc"><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>The crystallization and data collection of topoisomerase IV from S. aureus is described. </plain></SENT>
<SENT sid="2" pm="."><plain>Phasing by molecular replacement proved difficult owing to the presence of translational NCS and strategies used to overcome this are discussed. </plain></SENT>
</text></SecTag></p></abstract><abstract><p><SecTag type="ABS"><text><SENT sid="3" pm="."><plain>DNA topoisomerase IV removes undesirable topological features from DNA molecules in order to help maintain chromosome stability. </plain></SENT>
<SENT sid="4" pm="."><plain>Two constructs of 56 and 59 kDa spanning the DNA-cleavage domain of the A subunit of topoisomerase IV from Staphylococcus aureus (termed GrlA56 and GrlA59) have been crystallized. </plain></SENT>
<SENT sid="5" pm="."><plain>Crystals were grown at 291 K using the sitting-drop vapour-diffusion technique with PEG 3350 as a precipitant. </plain></SENT>
<SENT sid="6" pm="."><plain>Preliminary X-­ray analysis revealed that GrlA56 crystals belong to space group P21, diffract to a resolution of 2.9 Å and possess unit-cell parameters a = 83.6, b = 171.5, c = 87.8 Å, β = 90.1°, while crystals of GrlA59 belong to space group P21212, with unit-cell parameters a = 41.5, b = 171.89, c = 87.9 Å. </plain></SENT>
<SENT sid="7" pm="."><plain>These crystals diffract to a resolution of 2.8 Å. </plain></SENT>
<SENT sid="8" pm="."><plain>This is the first report of the crystallization and preliminary X-ray analysis of the DNA-cleavage domain of a topoisomerase IV from a Gram-positive organism. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>topoisomerase IV</kwd><kwd>DNA cleavage</kwd><kwd>quinolone binding</kwd><kwd>translational NCS</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec sec-type="introduction" id="sec1"><label>1.</label><title><text><SENT sid="9" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="10" pm="."><plain>DNA is prone to topological problems owing to its double-helical structure and the intertwining of its complementary strands. </plain></SENT>
<SENT sid="11" pm="."><plain>For example, during replication the unwinding of the chromosome forces adjacent regions of DNA to overwind and underwind, generating a superhelical strain (Wu et al., 1988 ▶). </plain></SENT>
<SENT sid="12" pm="."><plain>The removal of this intermolecular strain is vital for the prevention of DNA tangling and knotting, which produces structures that can lead to the formation of double-stranded breaks in the DNA and chromosome instability (Kato et al., 1990 ▶); furthermore, it is essential that circular daughter chromosomes of bacteria are disentangled at cell division. </plain></SENT>
<SENT sid="13" pm="."><plain>The resolution of such structures is performed by topoisomerase IV (topoIV), a type IIA DNA topoisomerase, which can remove these regions of unusual topology by passing one double-helical segment of DNA through another. </plain></SENT>
</text></p><p><text><SENT sid="14" pm="."><plain>All bacterial type IIA topoisomerases are A 2 B 2 heterotetramers containing three discrete subunit interfaces which open and close sequentially in response to ATP binding and hydrolysis in order to effect DNA transport (Wang, 1998 ▶). </plain></SENT>
<SENT sid="15" pm="."><plain>One segment of DNA (termed the gate segment) is initially bound by the A subunit, followed by the capture of a second strand (termed the transfer segment) by the B subunits as they bind ATP and dimerize. </plain></SENT>
<SENT sid="16" pm="."><plain>The dimerization and ensuing interaction with the A subunits triggers the cleavage of the gate segment. </plain></SENT>
<SENT sid="17" pm="."><plain>Subsequent hydrolysis of ATP causes the transfer segment to be passed through the DNA gate. </plain></SENT>
<SENT sid="18" pm="."><plain>DNA passage is followed by resealing of the gate segment and release of the transfer segment from the enzyme (Corbett &amp; Berger, 2004 ▶). </plain></SENT>
</text></p><p><text><SENT sid="19" pm="."><plain>Topoisomerases perform such a vital role in the maintenance of genetic stability within the cell that they are ideal drug targets and are the site of action of numerous antibacterial agents (Hooper, 2001 ▶). </plain></SENT>
<SENT sid="20" pm="."><plain>One class of inhibitor includes the quinolone antibiotics, which have proven to be highly effective against a variety of bacterial species (Oliphant &amp; Green, 2002 ▶). </plain></SENT>
<SENT sid="21" pm="."><plain>These molecules bind to the A subunit and stabilize the topoisomerase–DNA complex formed during the catalytic turnover of the enzyme. </plain></SENT>
<SENT sid="22" pm="."><plain>The stalled topoisomerase complex then acts as a physical barrier to DNA replication. </plain></SENT>
<SENT sid="23" pm="."><plain>Collision of an active replication complex with the topoisomerase is thought to lead to the double-stranded breaks necessary for cell lethality (Drlica &amp; Zhao, 1997 ▶), although the exact mechanism by which this occurs is unknown. </plain></SENT>
</text></p><p><text><SENT sid="24" pm="."><plain>Topoisomerase IV has been shown to be the primary target for quinolones in Gram-positive species (Oliphant &amp; Green, 2002 ▶), but currently structural information is only available for the DNA-cleavage domains of topoisomerases from eukaryotic (PDB code <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/explore.do?structureId=1bgw">1bgw</ext-link>; Berger et al., 1996 ▶) and Gram-negative bacterial species (PDB codes <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/explore.do?structureId=1ab4">1ab4</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/explore.do?structureId=1zvu">1zvu</ext-link>; Morais-Cabral et al., 1997 ▶; Corbett et al., 2005 ▶). </plain></SENT>
<SENT sid="25" pm="."><plain>Here, we describe the crystallization and X-ray analysis of two different constructs of the A subunit of topoisomerase IV from Staphylococcus aureus (GrlA) with a view to gaining further insight into the mode of inhibition of quinolone antibiotics against this enzyme. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="sec2"><label>2.</label><title><text><SENT sid="26" pm="."><plain>Materials and methods </plain></SENT>
</text></title><sec id="sec2.1"><label>2.1.</label><title><text><SENT sid="27" pm="."><plain>Purification </plain></SENT>
</text></title><p><text><SENT sid="28" pm="."><plain>Full details of the expression and purification are given elsewhere (Carr et al., 2006 ▶). </plain></SENT>
<SENT sid="29" pm="."><plain>Briefly, the two constructs encompassing the N-­terminal domains of S. aureus GrlA (accession code D67075) were generated by PCR from genomic DNA into the expression vector pET15b, such that 23 amino acids derived from the vector (including a hexahistidine tag) are fused to codons 25–491 or 1–491 of GrlA. </plain></SENT>
<SENT sid="30" pm="."><plain>This leads to the generation of proteins with molecular weights of approximately 56 kDa (GrlA56) and approximately 59 kDa (GrlA59), respectively. </plain></SENT>
<SENT sid="31" pm="."><plain>Protein expression was performed in Escherichia coli B834 DE3 (plysS) cultures by incubation at 310 K for 3 h after the addition of IPTG to a final concentration of 0.5 mM. </plain></SENT>
<SENT sid="32" pm="."><plain>Cells were lysed by sonication in 50 mM Tris–HCl pH 7.5, 400 mM KCl, 10%(v/v) ethanediol and debris was removed by centrifugation (12 000g for 30 min). </plain></SENT>
<SENT sid="33" pm="."><plain>The resulting supernatant was loaded onto a column of HP chelating Sepharose (GE Healthcare), previously charged with nickel, and eluted with a 0–500 mM imidazole gradient. </plain></SENT>
<SENT sid="34" pm="."><plain>Protein-containing fractions were pooled and diluted with 50 mM Tris–HCl pH 7.5, 10%(v/v) ethanediol to a final KCl concentration of 75 mM. </plain></SENT>
<SENT sid="35" pm="."><plain>This material was then loaded onto a column of heparin Sepharose (GE Healthcare) pre-equilibrated with 50 mM Tris–HCl pH 7.5, 75 mM KCl, 10%(v/v) ethanediol. </plain></SENT>
<SENT sid="36" pm="."><plain>Protein was then eluted with a 0–1 M KCl gradient. </plain></SENT>
<SENT sid="37" pm="."><plain>Samples containing GrlA56 or GrlA59 were identified by absorbance at 280 nm and SDS–PAGE analysis. </plain></SENT>
<SENT sid="38" pm="."><plain>The purified proteins were extensively dialysed against 50 mM Tris–HCl pH 7.5, 400 mM KCl, 10%(v/v) ethanediol and concentrated to 5 mg ml−1 in an ultrafiltration cell (Millipore, 10 kDa cutoff). </plain></SENT>
</text></p></sec><sec id="sec2.2"><label>2.2.</label><title><text><SENT sid="39" pm="."><plain>Crystallization </plain></SENT>
</text></title><p><text><SENT sid="40" pm="."><plain>Initial crystallization conditions were obtained by sparse-matrix screening (Jancarik &amp; Kim, 1991 ▶) using the sitting-drop vapour-diffusion technique. </plain></SENT>
<SENT sid="41" pm="."><plain>Drops were prepared by mixing 0.5 µl protein solution with 0.5 µl screen solution using an Oryx6 liquid-handling robot (Douglas Instruments) and were equilibrated against a 100 µl reservoir of screen solution at 291 K. </plain></SENT>
<SENT sid="42" pm="."><plain>Initial crystals of both GrlA56 and GrlA59 appeared after 5 d from Index Screen solution No. 73 [100 mM Tris pH 8.5, 200 mM NaCl and 25%(w/v) PEG 3350; Hampton Research]. </plain></SENT>
<SENT sid="43" pm="."><plain>Streak-seeding into drops (2 µl protein and 2 µl 100 mM Tris pH 8.3–8.5, 200 mM NaCl and 12–16% PEG 3350) pre-equilibrated for 1–2 h against a 0.5 ml reservoir produced large diffraction-quality crystals for both constructs. </plain></SENT>
</text></p></sec><sec id="sec2.3"><label>2.3.</label><title><text><SENT sid="44" pm="."><plain>Data collection </plain></SENT>
</text></title><p><text><SENT sid="45" pm="."><plain>Crystals were transferred into 100 mM Tris pH 8.5, 200 mM NaCl, 20%(w/v) PEG 3350 and 25% ethanediol prior to flash-cooling by immersion in liquid nitrogen. </plain></SENT>
<SENT sid="46" pm="."><plain>Data collection was performed at 100 K on station ID23.2, ESRF, France with a MAR CCD image-plate detector (MAR Research). </plain></SENT>
<SENT sid="47" pm="."><plain>Data were collected in multiple batches spanning 30° (0.5° oscillations), each separated by a translation of 50 µm along the long axis of the crystal, in order to minimize radiation damage. </plain></SENT>
<SENT sid="48" pm="."><plain>Diffraction data were integrated using MOSFLM (Leslie, 1992 ▶), followed by scaling and merging using SCALA (Evans, 1997 ▶). </plain></SENT>
<SENT sid="49" pm="."><plain>Further data analysis was performed using various programs from the CCP4 program suite (Collaborative Computational Project, Number 4, 1994 ▶). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS,DISCUSS"><sec sec-type="discussion|interpretation" id="sec3"><label>3.</label><title><text><SENT sid="50" pm="."><plain>Results and discussion </plain></SENT>
</text></title><p><text><SENT sid="51" pm="."><plain>Crystals of both protein fragments displayed a plate-like morphology and initially grew in tightly packed clusters. </plain></SENT>
<SENT sid="52" pm="."><plain>Streak-seeding proved the most effective method of producing large single crystals suitable for diffraction analysis (Figs. </plain></SENT>
<SENT sid="53" pm="."><plain>1 ▶ a and 1 ▶ b). </plain></SENT>
<SENT sid="54" pm="."><plain>The diffraction images collected from crystals of GrlA56 were unusual in that they contained strong reflections when the h index was even and weak reflections when h was odd (Fig. 2 ▶). </plain></SENT>
</text></p><p><text><SENT sid="55" pm="."><plain>The GrlA56 crystals belong to space group P21 (Table 1 ▶) and could contain between two and six copies of the construct per asymmetric unit, with four copies corresponding to a solvent content of 56% (Matthews, 1968 ▶). </plain></SENT>
<SENT sid="56" pm="."><plain>Calculation of a self-rotation function (Fig. 3 ▶) reveals the presence of orthorhombic pseudosymmetry, so the data were rescaled applying the pseudosymmetry (P21212) indicated by inspection of systematic absences. </plain></SENT>
<SENT sid="57" pm="."><plain>Preliminary attempts at molecular replacement into the pseudo-cell using AMoRe (Navaza, 1994 ▶) were performed using the complete model of the 59 kDa fragment of DNA gyrase from E. coli (PDB code <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/explore.do?structureId=1ab4">1ab4</ext-link>; Morais Cabral et al., 1997 ▶). </plain></SENT>
<SENT sid="58" pm="."><plain>This revealed a dimer within the asymmetric unit with an intermolecular twofold axis coincident with the crystallographic twofold. </plain></SENT>
<SENT sid="59" pm="."><plain>A slight distortion of the molecules that shifted the molecular twofold away from the crystallographic twofold would result in a lower symmetry monoclinic space group. </plain></SENT>
</text></p><p><text><SENT sid="60" pm="."><plain>Applying a solvent content of 56% to the monoclinic cell suggests the presence of four molecules per asymmetric unit. </plain></SENT>
<SENT sid="61" pm="."><plain>Knowledge of the packing within the crystal suggests they should be arranged as a pair of dimers related by a direct translation of a/2 and each possessing a noncrystallographic twofold axis almost parallel to c. </plain></SENT>
<SENT sid="62" pm="."><plain>This packing also accounts for the presence of weak h odd reflections in the diffraction pattern, as the similar orientation of each pair of dimers results in the strong reflections corresponding to a unit cell with a cell edge of a/2 interspersed with weak intensities generated solely by the small differences between the two independent dimers. </plain></SENT>
<SENT sid="63" pm="."><plain>Further refinement of this model was severely impeded by the translational NCS relating each dimer within the asymmetric unit and this led to the redesign and production of the GrlA59 construct. </plain></SENT>
</text></p><p><text><SENT sid="64" pm="."><plain>Crystals of GrlA59 belong to space group P21212 (Table 1 ▶), contain one molecule per asymmetric unit and have a solvent content of 56%. </plain></SENT>
<SENT sid="65" pm="."><plain>The unit cell is related to that observed for GrlA56 crystals, but slight differences in packing have increased the order within the crystals, leading to the smaller unit cell and higher symmetry. </plain></SENT>
<SENT sid="66" pm="."><plain>It is possible that the additional residues at the N-terminus have created extra crystal contacts. </plain></SENT>
<SENT sid="67" pm="."><plain>It is likely that the orientation of the monomer within the asymmetric unit is such that the intermolecular twofold axis is parallel to c. </plain></SENT>
<SENT sid="68" pm="."><plain>Molecular replacement performed as previously described for GrlA56 confirm this assertion, generating a model suitable for rebuilding and refinement. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="69" pm="."><plain>We would like to thank Val Sergeant for technical support and David Flot (ID23.2, ESRF) for assistance during data collection. </plain></SENT>
<SENT sid="70" pm="."><plain>We would also like to thank the Wellcome Trust for funding. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="bb1"><text><SENT sid="71" pm="."><plain>Berger, J. </plain></SENT>
<SENT sid="72" pm="."><plain>M., Gamblin, S. </plain></SENT>
<SENT sid="73" pm="."><plain>J., Harrison, S. </plain></SENT>
<SENT sid="74" pm="."><plain>C. &amp; Wang, J. </plain></SENT>
<SENT sid="75" pm="."><plain>C. </plain></SENT>
<SENT sid="76" pm="."><plain>(1996). Nature (London), 379, 225–232. </plain></SENT>
</text></ref><ref id="bb2"><text><SENT sid="77" pm="."><plain>Carr, S. </plain></SENT>
<SENT sid="78" pm="."><plain>B., Makris, G., Cove, J. </plain></SENT>
<SENT sid="79" pm="."><plain>H., Phillips, S. </plain></SENT>
<SENT sid="80" pm="."><plain>E. </plain></SENT>
<SENT sid="81" pm="."><plain>V. &amp; Thomas, C. </plain></SENT>
<SENT sid="82" pm="."><plain>D. </plain></SENT>
<SENT sid="83" pm="."><plain>(2006). </plain></SENT>
<SENT sid="84" pm="."><plain>In preparation. </plain></SENT>
</text></ref><ref id="bb3"><text><SENT sid="85" pm="."><plain>Collaborative Computational Project, Number 4 (1994). Acta Cryst. D50, 760–­763. </plain></SENT>
</text></ref><ref id="bb4"><text><SENT sid="86" pm="."><plain>Corbett, K. </plain></SENT>
<SENT sid="87" pm="."><plain>D. &amp; Berger, J. </plain></SENT>
<SENT sid="88" pm="."><plain>M. </plain></SENT>
<SENT sid="89" pm="."><plain>(2004). Annu. </plain></SENT>
<SENT sid="90" pm="."><plain>Rev. </plain></SENT>
<SENT sid="91" pm="."><plain>Biophys. </plain></SENT>
<SENT sid="92" pm="."><plain>Biomol. </plain></SENT>
<SENT sid="93" pm="."><plain>Struct.33, 95–118. </plain></SENT>
</text></ref><ref id="bb5"><text><SENT sid="94" pm="."><plain>Corbett, K. </plain></SENT>
<SENT sid="95" pm="."><plain>D., Schoeffler, A. </plain></SENT>
<SENT sid="96" pm="."><plain>J., Thomsen, N. </plain></SENT>
<SENT sid="97" pm="."><plain>D. &amp; Berger, J. </plain></SENT>
<SENT sid="98" pm="."><plain>M. </plain></SENT>
<SENT sid="99" pm="."><plain>(2005). J. </plain></SENT>
<SENT sid="100" pm="."><plain>Mol. </plain></SENT>
<SENT sid="101" pm="."><plain>Biol.351, 545–561. </plain></SENT>
</text></ref><ref id="bb6"><text><SENT sid="102" pm="."><plain>Drlica, K. &amp; Zhao, X. </plain></SENT>
<SENT sid="103" pm="."><plain>L. </plain></SENT>
<SENT sid="104" pm="."><plain>(1997). Microbiol. </plain></SENT>
<SENT sid="105" pm="."><plain>Mol. </plain></SENT>
<SENT sid="106" pm="."><plain>Biol. </plain></SENT>
<SENT sid="107" pm="."><plain>Rev.61, 377–392. </plain></SENT>
</text></ref><ref id="bb7"><text><SENT sid="108" pm="."><plain>Evans, P. </plain></SENT>
<SENT sid="109" pm="."><plain>R. </plain></SENT>
<SENT sid="110" pm="."><plain>(1997). Jnt CCP4/ESF–EACBM Newsl. </plain></SENT>
<SENT sid="111" pm="."><plain>Protein Crystallogr.33, 22–24. </plain></SENT>
</text></ref><ref id="bb8"><text><SENT sid="112" pm="."><plain>Hooper, D. </plain></SENT>
<SENT sid="113" pm="."><plain>C. </plain></SENT>
<SENT sid="114" pm="."><plain>(2001). Clin. </plain></SENT>
<SENT sid="115" pm="."><plain>Infect. </plain></SENT>
<SENT sid="116" pm="."><plain>Dis.32, Suppl. 1, S9–S15. </plain></SENT>
</text></ref><ref id="bb9"><text><SENT sid="117" pm="."><plain>Jancarik, J. &amp; Kim, S.-H (1991). J. </plain></SENT>
<SENT sid="118" pm="."><plain>Appl. </plain></SENT>
<SENT sid="119" pm="."><plain>Cryst.24, 409–411. </plain></SENT>
</text></ref><ref id="bb10"><text><SENT sid="120" pm="."><plain>Kato, J., Nishimura, Y., Imamura, R., Niki, H., Hirago, S. &amp; Suzuki, H. </plain></SENT>
<SENT sid="121" pm="."><plain>(1990). Cell, 63, 393–404. </plain></SENT>
</text></ref><ref id="bb11"><text><SENT sid="122" pm="."><plain>Leslie, A. </plain></SENT>
<SENT sid="123" pm="."><plain>G. </plain></SENT>
<SENT sid="124" pm="."><plain>W. </plain></SENT>
<SENT sid="125" pm="."><plain>(1992). Jnt CCP4/ESF–EACBM Newsl. </plain></SENT>
<SENT sid="126" pm="."><plain>Protein Crystallogr.26 </plain></SENT>
</text></ref><ref id="bb12"><text><SENT sid="127" pm="."><plain>Matthews, B. </plain></SENT>
<SENT sid="128" pm="."><plain>W. </plain></SENT>
<SENT sid="129" pm="."><plain>(1968). J. </plain></SENT>
<SENT sid="130" pm="."><plain>Mol. </plain></SENT>
<SENT sid="131" pm="."><plain>Biol.33, 491–497. </plain></SENT>
</text></ref><ref id="bb13"><text><SENT sid="132" pm="."><plain>Morais Cabral, J. </plain></SENT>
<SENT sid="133" pm="."><plain>H., Jackson, A. </plain></SENT>
<SENT sid="134" pm="."><plain>P., Smith, C. </plain></SENT>
<SENT sid="135" pm="."><plain>V., Shikotra, N., Maxwell, A. &amp; Liddington, R. </plain></SENT>
<SENT sid="136" pm="."><plain>C. </plain></SENT>
<SENT sid="137" pm="."><plain>(1997). Nature (London), 388, 903–906. </plain></SENT>
</text></ref><ref id="bb14"><text><SENT sid="138" pm="."><plain>Navaza, J. </plain></SENT>
<SENT sid="139" pm="."><plain>(1994). Acta Cryst. A50, 157–163. </plain></SENT>
</text></ref><ref id="bb15"><text><SENT sid="140" pm="."><plain>Oliphant, C. </plain></SENT>
<SENT sid="141" pm="."><plain>M. &amp; Green, G. </plain></SENT>
<SENT sid="142" pm="."><plain>M. </plain></SENT>
<SENT sid="143" pm="."><plain>(2002). Am. </plain></SENT>
<SENT sid="144" pm="."><plain>Fam. </plain></SENT>
<SENT sid="145" pm="."><plain>Physician, 65, 455–464. </plain></SENT>
</text></ref><ref id="bb16"><text><SENT sid="146" pm="."><plain>Wang, J. </plain></SENT>
<SENT sid="147" pm="."><plain>C. </plain></SENT>
<SENT sid="148" pm="."><plain>(1998). Q. </plain></SENT>
<SENT sid="149" pm="."><plain>Rev. </plain></SENT>
<SENT sid="150" pm="."><plain>Biophys.31, 107–144. </plain></SENT>
</text></ref><ref id="bb17"><text><SENT sid="151" pm="."><plain>Wu, H. </plain></SENT>
<SENT sid="152" pm="."><plain>Y., Shyy, S., Wang, J. </plain></SENT>
<SENT sid="153" pm="."><plain>C. &amp; Liu, L. </plain></SENT>
<SENT sid="154" pm="."><plain>F. </plain></SENT>
<SENT sid="155" pm="."><plain>(1988). Cell, 53, 433–440. </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-wrap><SecTag type="FIG"><fig id="fig1" position="float"><label>Figure 1</label><caption><p>(<italic>a</italic>) A monoclinic crystal of GrlA56; typical dimensions are 400 × 300 × 20 µm. (<italic>b</italic>) An orthorhombic crystal of GrlA59 mounted in a cryoloop prior to data collection; typical dimensions are 500 × 150 × 20 µm.</p></caption><graphic xlink:href="f-62-01164-fig1"/></fig></SecTag><SecTag type="FIG"><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Diffraction pattern observed for GrlA56 crystals, with the differences in intensity between weak <italic>h</italic>
                  <sub>odd</sub> and strong <italic>h</italic>
                  <sub>even</sub> reflections highlighted.</p></caption><graphic xlink:href="f-62-01164-fig2"/></fig></SecTag><SecTag type="FIG"><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Self-rotation function (κ = 180°) calculated for GrlA56 reveals orthorhombic pseudosymmetry within the monoclinic crystal lattice.</p></caption><graphic xlink:href="f-62-01164-fig3"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="table1" position="float"><label>Table 1</label><caption><title>GrlA56 and GrlA59 X-ray diffraction data-collection statistics</title><p>Values in parentheses are for the highest resolution bin.</p></caption><table-wrap-foot><fn id="tfn1"><label>†</label><p>
                     <italic>R</italic>
                     <sub>merge</sub> = <inline-formula><inline-graphic xlink:href="f-62-01164-efi1.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>
                     <inline-formula><inline-graphic xlink:href="f-62-01164-efi2.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>, where <italic>I</italic>
                     <sub><italic>l</italic></sub> is the <italic>l</italic>th observation of reflection <bold>h</bold> and 〈<italic>I</italic>
                     <sub><bold>h</bold></sub>〉 is the weighted average intensity for all observations <italic>l</italic> of reflection <bold>h</bold>.</p></fn></table-wrap-foot></table-wrap></SecTag></floats-wrap></article>
